leonurine has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Chen, Z; Huang, Z; Li, Q; Liu, X; Qi, J; Wu, L; Xing, C; Yuan, Y; Zhang, B; Zhao, M; Zhu, J | 1 |
| Bo, Y; Cheng, H; Jia, Z; Li, F; Shen, W; Tan, J; Xu, C | 1 |
2 other study(ies) available for leonurine and Kidney Diseases
| Article | Year |
|---|---|
Leonurine ameliorates adriamycin-induced podocyte injury via suppression of oxidative stress.
Topics: Animals; Apoptosis; Disease Models, Animal; Doxorubicin; Gallic Acid; Humans; Kidney; Kidney Diseases; Macrophages; Mice; Oxidative Stress; Podocytes; Proteinuria; Reactive Oxygen Species; Wounds and Injuries | 2018 |
Leonurine ameliorates kidney fibrosis via suppressing TGF-β and NF-κB signaling pathway in UUO mice.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Gallic Acid; Kidney; Kidney Diseases; Mice, Inbred C57BL; NF-kappa B; Protective Agents; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta; Urethral Obstruction | 2015 |